High-dose or dose-intensive cytotoxic chemotherapy often causes myelosuppression and severe neutropenia among cancer patients. Severe neutropenia accompanied by fever, named febrile neutropenia (FN), is the most serious manifestation of neutropenia usually requiring hospitalization and intravenous antibiotics. FN and neutropenia can lead to chemotherapy treatment delays or dose reductions, which potentially compromises the effectiveness of cancer treatment and prospects for a cure. Granulocyte-macrophage (GM) and granulocyte colony-stimulating factors (G-CSFs) are administered during chemotherapy in order to prevent or reduce the incidence or the duration of FN and neutropenia
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
PURPOSE: Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining...
Neutropenia is a severe and very frequent complication of anticancer chemotherapy. Febrile neutropen...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
There is good evidence to suggest that dose intensity is important when considering the effectivenes...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
PURPOSE: Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining...
Neutropenia is a severe and very frequent complication of anticancer chemotherapy. Febrile neutropen...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
Purpose Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining ...
There is good evidence to suggest that dose intensity is important when considering the effectivenes...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
International audienceCytotoxic chemotherapy suppresses the haematopoietic system, impairing host pr...
PURPOSE: Early breast cancer is commonly treated with anthracyclines and taxanes. However, combining...
Neutropenia is a severe and very frequent complication of anticancer chemotherapy. Febrile neutropen...